Doctor profile · Federal record
Dr. Joseph Mock, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Blacksburg, VA
- NPI 1194111005
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 11 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2600 Research Center Dr Ste A
Blacksburg, VA 240606325
(540) 381-5291
fax (540) 381-7857 - Mailing address
-
2013 Jefferson St Sw Fl 2
Roanoke, VA 240142419
Credentials & registration
- NPI registered
- April 2015 — 11 yrs on file
- Profile last updated
- August 5, 2021
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Virginia #0101271641
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194111005. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
142,910
Distinct HCPCS
10
Medicare allowed
$2,300,758
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 49,500 | 51 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 14,200 | 18 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 14,020 | 14 | $30 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,990 | 20 | $3 | |
J9267 |
Injection, paclitaxel, 1 mg | 8,514 | 16 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 7,540 | 24 | $2 | |
J1453 |
Injection, fosaprepitant, 1 mg | 7,200 | 17 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 6,300 | 11 | $48 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 3,364 | 21 | $29 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 3,156 | 16 | $42 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 1,851. This provider delivers 77× the peer median.Open Payments
Industry payments received
All-time total
$1,442
Transactions
44
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $115.06 | |
| Daiichi Sankyo Inc. | 4 | $105.12 | |
| Astellas Pharma US Inc | 4 | $98.10 | |
| GlaxoSmithKline, LLC. | 4 | $91.26 | |
| ABBVIE INC. | 4 | $83.43 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $82.40 | |
| Genmab U.S., Inc. | 3 | $71.21 | |
| Eisai Inc. | 3 | $59.56 | |
| Incyte Corporation | 2 | $54.36 | |
| Ipsen Biopharmaceuticals, Inc | 2 | $50.51 | |
| PFIZER INC. | 2 | $45.30 | |
| BeiGene USA, Inc. | 2 | $40.79 | |
| Merck Sharp & Dohme LLC | 2 | $39.36 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37.16 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $35.73 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,111
Patients
341
Total drug cost
$106,826
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 139 | 36 | $743 |
| Ondansetron Hcl | Generic | 114 | 58 | $2,116 |
| Oxycodone Hcl | Generic | 107 | 38 | $2,805 |
| Eliquis (Apixaban) | Brand | 94 | 22 | $86,748 |
| Olanzapine | Generic | 86 | 40 | $3,131 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 81 | 29 | $1,552 |
| Letrozole | Generic | 76 | 19 | $1,886 |
| Anastrozole | Generic | 71 | 16 | $1,702 |
| Dexamethasone | Generic | 68 | 24 | $836 |
| Tamoxifen Citrate | Generic | 58 | 15 | $1,896 |
Hospital affiliations
Frequently asked questions
What is Dr. Joseph Mock's medical specialty?
Dr. Joseph Mock practices Hematology & Oncology Physician in Blacksburg, VA.
Where does Dr. Joseph Mock practice?
Dr. Joseph Mock practices at 2600 Research Center Dr Ste A, Blacksburg, VA 240606325. Office phone: 5403815291.
What is Dr. Joseph Mock's NPI?
Dr. Joseph Mock's National Provider Identifier (NPI) is 1194111005, issued by NPPES.
Does Dr. Joseph Mock accept Medicare assignment?
Yes. Dr. Joseph Mock accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Joseph Mock commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.